Markets:

Overview

News

Currencies

International

Treasuries

Hoth Therapeutics, Inc. - Common Stock (NQ:HOTH)

1.360 UNCHANGED

Last Price Updated: 4:00 PM EDT, May 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Hoth Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Hoth Therapeutics Announces Submission of Orphan Designation Application for HT-KIT to Treat Mastocytosis ↗

December 21, 2021

NEW YORK, NY December 21, 2021 /PRNewswire/ Hoth Therapeutics, Inc. (NASDAQ: HOTH) a patient-focused clinical-stage biopharmaceutical company, announced...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 20, 2021

Gainers ACADIA Pharmaceuticals (NASDAQ:ACAD

Via Benzinga

Hoth Therapeutics Reports Finishing Up a Busy Year of Research Across its Portfolio of Drug Candidates ↗

December 20, 2021

Image provided by Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of...

Via Benzinga

EXCLUSIVE: Hoth Therapeutics Gives Cannabinoid-Based Lupus Candidate Back To Zylö ↗

December 08, 2021

Hoth Therapeutics Inc (NASDAQ: HOTH) has agreed to license its cannabinoid therapeutic, HT-005, for lupus patients back to Zylö Therapeutics. What Happened: In August 2019,...

Via Benzinga

Early Clinical Data Suggest This New Lotion Could Offer Best-In-Class Eczema Treatment and Infection Prevention, According to Hoth Therapeutics ↗

December 07, 2021

Image Provided By Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of...

Via Benzinga

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline ↗

August 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business ↗

August 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 01, 2021

Gainers Hoth Therapeutics (NASDAQ:HOTH) s...

Via Benzinga

EXCLUSIVE: Hoth Therapeutics Starts Dosing In Second Cohort Of Atopic Dermatitis Trial With BioLexa ↗

November 30, 2021

Hoth Therapeutics Inc (NASDAQ: HOTH) has begun enrollment and dosing for the second cohort in its Phase 1b trial of topical BioLexa to treat mild to moderate atopic...

Via Benzinga

Hoth Inks Research Agreement With North Carolina State University For Study of Preclinical Candidate To Treat Mast Cell Cancers ↗

November 16, 2021

Hoth Therapeutics, Inc. (NASDAQ: HOTH) announced an oncology R&D collaboration on Tuesday. What Happened: New York-based Hoth, a biopharma focusing on new-age therapies for...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 16, 2021

Gainers Kezar Life Sciences (NASDAQ:KZR) stock rose 48.27% to $12.47 during Tuesday's pre-market session. The market value of their outstanding shares is at $612.8...

Via Benzinga

Hoth Therapeutics Enters Into Agreements with WuXi STA; Attempts to Get New Cancer Treatment Closer to Clinical Trials ↗

November 11, 2021

Photo by National Cancer Institute on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a...

Via Benzinga

This Company Says Its New Topical Therapy Trials Bringing Hope to People Exposed to Biofilm Bacteria ↗

November 09, 2021

Photo by Louis Reed on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner...

Via Benzinga

Clinical-Stage Biopharmaceutical Company HOTH Says It Is on a Mission to Develop Next-Generation Therapeutics to Meet Patient Needs ↗

November 03, 2021

Photo by Roberto Sorin on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...

Via Benzinga

Hoth Therapeutics Says the Possibilities Could Be Endless ↗

October 28, 2021

Photo by Hoth Therapeutics The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of...

Via Benzinga

Hoth Therapeutics Receives Approval to Commence Cohort 2 in Clinical Trial of BioLexa for the Treatment of Atopic Dermatitis in Humans ↗

October 12, 2021

NEW YORK, NY /PR Newswire/ Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that is has received Human Research Ethics...

Via Benzinga

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results ↗

October 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...

Via Benzinga

Alkido Pharma Trading 30% Below Cash Value Despite Positive Indications ↗

October 06, 2021

Photo by Joshua Mayo on Unsplash Biotechnology development company AIkido Pharma Inc. (NASDAQ: AIKI) recently released its 1st-quarter report, which revealed the strongest balance...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 08, 2021

Gainers Kadmon Holdings (NASDAQ:KDMN) shares rose 73.39% to $9.19 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.5...

Via Benzinga

EXCLUSIVE: Hoth Reports Safety Data From Early-Stage Study Of BioLexa Platform In Eczema ↗

September 08, 2021

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharma engaged in the development of therapies for unmet need, releases positive early-stage data for its BioLexa...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 01, 2021

Gainers INmune Bio (NASDAQ:INMB) shares ...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 18, 2021

Gainers Protagenic Therapeutics (NASDAQ:PTIX...

Via Benzinga

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal ↗

October 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...

Via Benzinga

The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO ↗

August 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 11, 2021

Gainers CohBar (NASDAQ:CWBR) stock moved upwards by 68.21% to $2.17 during Wednesday's pre-market session. The company's market cap stands at $134.0 million. The...

Via Benzinga

22 Stocks Moving in Wednesday's Pre-Market Session ↗

August 11, 2021

Gainers CohBar, Inc. (NASDAQ: CWBR) shares rose 78.3% to $2.30 in pre-market trading after the company reported results from the Phase 1a/1b study of CB4211 under development for...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 03, 2021

Gainers Cerus (NASDAQ:CERS) shares incre...

Via Benzinga

Hoth Therapeutics Starts Preclinical Study For Its Alzheimer's Candidate ↗

August 02, 2021

Hoth Therapeutics Inc (NASDAQ: HOTH) has initiated its preclinical study utilizing Hoth's HT-ALZ in an animal model. The study aims to determine the effects of...

Via Benzinga

Hoth Therapeutics' HT-003 Shows Encouraging Action Against Acne In Animal Model ↗

July 13, 2021

Hoth Therapeutics Inc (NASDAQ: HOTH) has announced that its HT-003 group of assets has yielded positive results in an in vivo acne therapeutic model. The model...

Via Benzinga

Hoth Therapeutics Unveils Preclinical Results of HT-KIT Therapeutic Program ↗

June 03, 2021

Hoth Therapeutics Inc (NASDAQ: HOTH) has reported results from a preclinical trial of HT-KIT, a new molecular entity under development to treat mast cell-derived...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.